[{"Assets_0_FY_USD":1727424000.0,"CommonStockSharesConverted_0_FY_shares":55368000.0,"CommonStockSharesOutstanding_0_FY_shares":55368000.0,"EarningsPerShareBasic_1_FY_USD":-4.04,"EarningsPerShareBasic_4_FY_USD":-14.31,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-564384000.0,"NetIncomeLossConverted_1_FY_USD":-223347000.0,"NetIncomeLossConverted_4_FY_USD":-789608000.0,"StockholdersEquity_0_FY_USD":1284993000.0,"RevenuesConverted_1_FY_USD":9997000.0,"RevenuesConverted_4_FY_USD":44674000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200218"}]